Radar > 210567

La brasileña Eurofarma pone su mira en México para realizar una nueva adquisición

Intel ID : 210567
Synopsis
(content in spanish)

La compañía brasileña Eurofarma planea realizar una nueva adquisición en México de aquí hasta 2015. Tras la compra de la guatemalteca Laprin, la empresa prevé continuar creciendo en el sector farmacéutico latinoamericano.

En caso de que se lleve a cabo esta operación, supondría la sexta adquisición que realiza el laboratorio brasileño fuera de sus fronteras desde 2009.

Bidder


Intel ID 210567
Value ND
Native Currency US Dollar (USD)
Exchange Rate:
Financial Data - Eurofarma
(31 Dec 2024)
Revenue: EUR 1.713,09m
EBITDA: EUR 252,16m
Net Debt: EUR 1.171,83m
Exchange Rate:
Date
Country
Region
Continent
Geography
Subsector (Old TTR Sectors)
Type
Intel Grade
Source
Tags

Bidder

Name
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Sectors (TTRSC)
10.01.03 Distributors & Wholesalers (B2B)
10 Business Services / 10.01 Business & Professional Support Services

10.01.13 Testing, Inspection and Certification (TIC) Services
10 Business Services / 10.01 Business & Professional Support Services

15.04.01 Cosmetics & Perfumes
15 Consumer Products & Services / 15.04 Consumer Nondurables

15.04.03 Personal Care Products
15 Consumer Products & Services / 15.04 Consumer Nondurables

15.05.08 Food & Beverage Retail
15 Consumer Products & Services / 15.05 Distribution & Retail

15.06.01 Colleges & Universities
15 Consumer Products & Services / 15.06 Education & Training Services

15.07.07 Health Food & Supplements
15 Consumer Products & Services / 15.07 Food

15.07.99 Other Food
15 Consumer Products & Services / 15.07 Food

15.09.02 Pet Food & Pet Supplies Manufacturing
15 Consumer Products & Services / 15.09 Pet Products & Services

30.01.01 Biopharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.01.04 Specialty Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.01.99 Other Biotechnology & Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.02.03 Healthcare Product Distributors
30 Healthcare / 30.02 Healthcare Equipment & Supplies

30.02.99 Other Healthcare Equipment & Supplies
30 Healthcare / 30.02 Healthcare Equipment & Supplies

35.04.01 Glass Containers & Packaging
35 Industrials / 35.04 Containers & Packaging

55.01.07 Livestock Production
55 Raw Materials & Natural Resources / 55.01 Agriculture, Fishing & Hunting

55.02.99 Other Chemicals
55 Raw Materials & Natural Resources / 55.02 Chemicals

Country
Website
Description

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.